Boomerang Medical

Boomerang is developing a technology to advance the treatment of autoimmune diseases by harnessing the body’s own “peripheral wiring” to manage inflammation and immune response.
Menlo Park, CA

CEO: Heather Simonsen
Arboretum Lead: Tom Shehab, MD

May 3, 2023 in Boomerang Medical, Home Page, News Page

NewYork-Presbyterian Enrolls First Patient in National Study of Sacral Nerve Stimulation Device for Inflammatory Bowel Disease

For Marco B. Zoccali, MD, FACS, a colorectal surgeon at NewYork-Presbyterian/Columbia, sacral nerve stimulation (SNS) has been a routine part of the care he provides to his patients with fecal incontinence.…
Read More
April 17, 2023 in Boomerang Medical, News Page

Boomerang Medical Announces First Patients Enrolled in Multi-Center Clinical Trial

Boomerang Medical, a women-led bioelectronic medicine company, has announced the enrollment of the first patients in its U.S. clinical trial evaluating the use of nerve stimulation as a potential treatment…
Read More